233 related articles for article (PubMed ID: 28620801)
21. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.
Mengr A; Hrubá L; Exnerová A; Holubová M; Popelová A; Železná B; Kuneš J; Maletínská L
Curr Alzheimer Res; 2021; 18(8):607-622. PubMed ID: 34551697
[TBL] [Abstract][Full Text] [Related]
22. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
23. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
24. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
Zhang J; Guo Y; Wang Y; Song L; Zhang R; Du Y
Neurosci Lett; 2018 Feb; 666():70-77. PubMed ID: 29246793
[TBL] [Abstract][Full Text] [Related]
25. Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice.
Lapeyre L; Piret J; Rhéaume C; Pons V; Uyar O; Préfontaine P; Rivest S; Boivin G
J Alzheimers Dis; 2024; 97(1):171-178. PubMed ID: 38143354
[TBL] [Abstract][Full Text] [Related]
26. Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid.
Pan Y; Short JL; Newman SA; Choy KHC; Tiwari D; Yap C; Senyschyn D; Banks WA; Nicolazzo JA
Brain Behav Immun; 2018 May; 70():36-47. PubMed ID: 29545118
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
29. Astrocyte hepcidin ameliorates neuronal loss through attenuating brain iron deposition and oxidative stress in APP/PS1 mice.
Xu Y; Zhang Y; Zhang JH; Han K; Zhang X; Bai X; You LH; Yu P; Shi Z; Chang YZ; Gao G
Free Radic Biol Med; 2020 Oct; 158():84-95. PubMed ID: 32707154
[TBL] [Abstract][Full Text] [Related]
30. Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe/PS1 Mice.
ElAli A; Bordeleau M; Thériault P; Filali M; Lampron A; Rivest S
Neuropsychopharmacology; 2016 Apr; 41(5):1297-307. PubMed ID: 26349911
[TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine.
Carrera I; Etcheverría I; Li Y; Fernández-Novoa L; Lombardi V; Vigo C; Palacios HH; Benberin VV; Cacabelos R; Aliev G
Biomed Res Int; 2013; 2013():709145. PubMed ID: 24089686
[TBL] [Abstract][Full Text] [Related]
32. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.
Krauthausen M; Kummer MP; Zimmermann J; Reyes-Irisarri E; Terwel D; Bulic B; Heneka MT; Müller M
J Clin Invest; 2015 Jan; 125(1):365-78. PubMed ID: 25500888
[TBL] [Abstract][Full Text] [Related]
33. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
34. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
[TBL] [Abstract][Full Text] [Related]
35. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
36. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
37. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
38. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.
Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Burchett JM; Schuler DR; Cirrito JR; Diwan A; Lee JM
J Neurosci; 2014 Jul; 34(29):9607-20. PubMed ID: 25031402
[TBL] [Abstract][Full Text] [Related]
39. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
40. Gas6 induces inflammation and reduces plaque burden but worsens behavior in a sex-dependent manner in the APP/PS1 model of Alzheimer's disease.
Owlett LD; Karaahmet B; Le L; Belcher EK; Dionisio-Santos D; Olschowka JA; Elliott MR; O'Banion MK
J Neuroinflammation; 2022 Feb; 19(1):38. PubMed ID: 35130912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
